Mark Whitmore

1.4k total citations
15 papers, 1.2k citations indexed

About

Mark Whitmore is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mark Whitmore has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Immunology and 2 papers in Oncology. Recurrent topics in Mark Whitmore's work include Immune Response and Inflammation (5 papers), Immunotherapy and Immune Responses (5 papers) and RNA Interference and Gene Delivery (5 papers). Mark Whitmore is often cited by papers focused on Immune Response and Inflammation (5 papers), Immunotherapy and Immune Responses (5 papers) and RNA Interference and Gene Delivery (5 papers). Mark Whitmore collaborates with scholars based in United States, Australia and Ireland. Mark Whitmore's co-authors include Leaf Huang, S Li, Bryan Williams, Louis D. Falo, Bryan R.G. Williams, Tsonwin Hai, Wolfgang Weninger, Amaya Iparraguirre, Simon C. Watkins and Lin Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Mark Whitmore

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Whitmore United States	10	678	532	231	139	93	15	1.2k
Chanchal Sadhu United States	17	551 0.8×	326 0.6×	124 0.5×	135 1.0×	146 1.6×	31	1.2k
Vasudevan Seshadri India	17	1.2k 1.8×	192 0.4×	109 0.5×	168 1.2×	110 1.2×	36	1.6k
P. F. Watson United Kingdom	25	387 0.6×	731 1.4×	495 2.1×	106 0.8×	110 1.2×	37	1.8k
Amir Tavakkol United States	20	803 1.2×	205 0.4×	285 1.2×	30 0.2×	76 0.8×	27	1.5k
Kyle M. Schachtschneider United States	19	539 0.8×	128 0.2×	273 1.2×	94 0.7×	203 2.2×	52	1.1k
Michael L. Sikes United States	15	620 0.9×	327 0.6×	206 0.9×	59 0.4×	182 2.0×	24	1.0k
Lan Chen China	21	606 0.9×	161 0.3×	106 0.5×	48 0.3×	146 1.6×	52	1.3k
Laura Timares United States	18	333 0.5×	388 0.7×	157 0.7×	54 0.4×	191 2.1×	27	944
John Wagner Canada	25	1.2k 1.8×	501 0.9×	184 0.8×	151 1.1×	186 2.0×	38	1.8k
Rita J. Proske United States	13	994 1.5×	372 0.7×	105 0.5×	57 0.4×	237 2.5×	19	1.6k

Countries citing papers authored by Mark Whitmore

Since Specialization

Citations

This map shows the geographic impact of Mark Whitmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Whitmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Whitmore more than expected).

Fields of papers citing papers by Mark Whitmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Whitmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Whitmore. The network helps show where Mark Whitmore may publish in the future.

Co-authorship network of co-authors of Mark Whitmore

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Whitmore. A scholar is included among the top collaborators of Mark Whitmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Whitmore. Mark Whitmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Gurel, Pinar S., et al.. (2025). Interleukin-18 (IL-18) engineered for half-life extension and resistance to IL-18 binding protein (IL-18BP) to enhance anti-cancer therapeutic potential. Cytokine. 193. 156979–156979.

Whitmore, Mark, et al.. (2025). Impact of Sex and Glial Tau Expression on Heat Shock Protein Induction in a Drosophila Model of Tauopathy. ACS Omega. 10(39). 45921–45932.

Shojaee, Mozhgan, Mark Whitmore, Michael Schoppet, et al.. (2020). Characterization of extracellular vesicles derived from two populations of human placenta derived mesenchymal stem/stromal cells. Cytotherapy. 22(5). S50–S50. 1 indexed citations

Whitmore, Mark, et al.. (2007). Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3. The Journal of Immunology. 179(6). 3622–3630. 174 indexed citations

White, Christine L., Mark Whitmore, & Bryan Williams. (2007). Enlarged Spleens Without Enlarged Lymph Nodes in tlr3 ^−/− pkr ^−/− Mice. Journal of Interferon & Cytokine Research. 27(1). 6–12. 1 indexed citations

Zhou, Yan, et al.. (2005). Double‐stranded RNA‐dependent protein kinase (PKR) is downregulated by phorbol ester. FEBS Journal. 272(7). 1568–1576. 9 indexed citations

Silva, Aristóbolo M., Mark Whitmore, Zan Xu, et al.. (2004). Protein Kinase R (PKR) Interacts with and Activates Mitogen-activated Protein Kinase Kinase 6 (MKK6) in Response to Double-stranded RNA Stimulation. Journal of Biological Chemistry. 279(36). 37670–37676. 76 indexed citations

Whitmore, Mark, Michael DeVeer, Andrea E. Edling, et al.. (2004). Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity. Cancer Research. 64(16). 5850–5860. 151 indexed citations

Tan, Yadi, Mark Whitmore, Song Li, Peter M. Frederik, & Leaf Huang. (2003). LPD Nanoparticles-Novel Nonviral Vector for Efficient Gene Delivery. Humana Press eBooks. 69. 73–81. 21 indexed citations

10.

DiLeo, John, Rintu Banerjee‬‬‬‬‬‬‬‬‬, Mark Whitmore, et al.. (2003). Lipid–protamine–DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses. Molecular Therapy. 7(5). 640–648. 50 indexed citations

11.

Khabar, Khalid S.A., Yunus M. Siddiqui, Fahad Al-Zoghaibi, et al.. (2003). RNase L Mediates Transient Control of the Interferon Response through Modulation of the Double-stranded RNA-dependent Protein Kinase PKR. Journal of Biological Chemistry. 278(22). 20124–20132. 50 indexed citations

12.

Whitmore, Mark, Song Li, Louis D. Falo, & Leaf Huang. (2001). Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunology Immunotherapy. 50(10). 503–514. 87 indexed citations

13.

Whitmore, Mark, S Li, & Leaf Huang. (1999). LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Therapy. 6(11). 1867–1875. 169 indexed citations

14.

Li, Song, Mark Whitmore, Lin Wang, et al.. (1999). Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. American Journal of Physiology-Lung Cellular and Molecular Physiology. 276(5). L796–L804. 188 indexed citations

15.

Lazo, J S, Jack C. Yalowich, Mark Whitmore, et al.. (1995). Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide.. Proceedings of the National Academy of Sciences. 92(10). 4452–4456. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact